TP53 and ovarian serous adenocarcinoma: Conversely, ALDH5A1 transcription and expression are associated with better overall survival in patients with serous ovarian cancer harboring TP53 mutations but not in patients with wild-type TP53, underscoring the differential role of ALDH enzymes in ovarian cancer pathogenesis and progression (54).